Abstract
In summarizing the clinical experience with 5-fluorouracil (FU) and folinic acid (FA) I shall approach it in the context of some critical questions which may be used to determine where we currently stand and where information still needs to be sought with respect to the clinical activity of this modulation. These questions are listed in Table 1.
Keywords
- International Symposium
- Cancer Chemotherapy
- Folinic Acid
- Advanced Colorectal Cancer
- Roswell Park Memorial Institute
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R.B. Livingston and S.K. Carter, “Single Agents in Cancer Chemotherapy”, IFI/Plenum, New York, 1970, pp. 202–206.
H. Bruckner, J. Roboz, M. Spiegelman, et al. An efficient leucovorin and 5-fluorouracil sequence: dosage escalation and pharmacological monitoring. Proc Am Assoc Cancer Res 24: 547 (1983).
D. Machover, E. Goldschimidt, P. Chollet, et al. Treatment of advanced colorectal and gastric adenocarcinoma with 5-fluorouracil and high-dose folinic acid. J Clin Oncol 4: 685 (1986).
P. Byrne, J. Treat, M. McFadden, et al. Therapeutic efficacy of the combination of 5-fluorouracil and high-dose leucovorin in patients with advanced colorectal carcinoma: single daily intravenous dose for five days, in: “The Current Status of 5-Fluorouracil-Leucovorin Combination,” H.W. Brucker and Y.M. Rustum, eds., Park Row Publishers, Inc., New York, 1984.
G.T. Budd, T. Fleming, J.D. Bukowski, et al. 5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group Study. J Clin Oncol 5: 272 (1987).
J.H. Doroshow; M. Bertrand, P. Multhauf, et al. Prospective randomized trial comparing 5-FU versus (vs) 5-FU and high dose folinic acid (HDFA) for treatment of advanced colorectal cancer. Proc Am Soc Clin Oncol 6: 96 (1987)
S. Madajewicz, N.J. Petrelli, Y. Rustum, et al. A phase I trial of high dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. Cancer Res 44: 4667 (1984).
N.J. Petrelli, Y.M. Rustum, H. Bruckner, et al. The Roswell Park Memorial Institute and Gastrointestinal Tumor Study Group phase III experience with the modulation of 5-fluorouracil by leucovorin in metastatic colorectal adenocarcinoma. in: “International Symposium on the Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy,” Y. Rustum and J. McGuire, eds., Plenum Press, New York, 1988, pp.
J.D. Hines, D.J. Adelstein, J.L. Spiess, et al. High-dose weekly oral leucovorin and 5-fluorouracil in previously untreated patients with advanced colorectal carcinoma: a phase I study. in: “International Symposium on the Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy,” Y. Rustum and J. McGuire, eds., Plenum Press, New York, 1988, pp.
J. Cunningham, R.M. Bukowski, G.T. Budd, et al. Fluorouracil and folinic acid: a phase I-II trial in gastrointestinal malignancy. Invest New Drugs 2: 391 (1984).
J. Mortimer and C. Higano. Continuous infusion 5-fluorouracil (FU) and folinic acid (FA) in disseminated colorectal cancer: a phase I-II study. Proc. Am. A. Cancer Res. 26: 171 (1985).
H. Greene, A. Desai, S. Levick, et al. Combined 5-fluorouracil infusion and high dose folinic acid in the treatment of metastatic gastrointestinal cancer. Proc Am Soc Clin Oncol 5: 89 (1986).
H.-J. Schmoll and S. Blanc, Sequential high dose folinic acid (FA) and 5-fluorouracil (5-FU) in advanced colorectal cancer with measurable, progressive disease. Proc Am Soc Clin Oncol 4: 94 (1985).
H. Wilke, H.-J. Schmoll, P. Preusser, et al. Folinic acid (CF)/5-fluorouracil (FUra) combinations in advanced gastrointestinal carcinomas. in: “International Symposium on the Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy,” Y. Rustum and J. McGuire, eds., Plenum Press, New York, 1988, pp.
E.H. Valone, T. Drakes, M. Flam, et al. A Northern California Oncology Group randomized trial of single agent 5-FU vs high-dose folinic acid + 5-FU vs methotrexate + 5-FU + folinic acid in patients with disseminated measurable large bowel cancer. Abst. of The Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy. April 1988. Buffalo. New York.
L.R. Laufman, W.D. Breckman, K.A. Stydnicki, et al. Clinical experience with CF-FUra. in: “International Symposium on the Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy.” Y. Rustum and J. McGuire, eds., Plenum Press. New York, 1988. pp.
L. Canobbio, M.T. Nobile, A. Sobrero, et al. A randomized trial of 5-fluorouracil alone versus 5-fluorouracil and high dose leucovorin (LV) in untreated advanced colorectal cancer patients. in: “International Symposium on the Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy.” Y. Rustum and J. McGuire. eds.. Plenum Press, New York. 1988. pp.
N. Petrelli, D. Stablein, H. Bruckner, et al. A prospective randomized phase III trial of 5-fluorouracil (5FU) versus 5FU + high dose leucovorin (HDCF) versus 5FU + low dose leucovorin (LDCF) in patients (pts) with metastatic colorectal adenocarcinoma. A report of the Gastrointestinal Tumor Study Group. Proc Am Soc Clin Oncol 7: 94 (1988).
C. Erlichman, Fluorouracil (FUra) and folinic acid (FA) therapy in patients with colorectal cancer. in: “International Symposium on the Expanding Role of Folates andoropyrimidines in Cancer Chemotherapy,” Y. Rustum and J. McGuire, eds., Plenum Press, New York, 1988. pp.
M.J. O’Connell. A controlled clinical trial including folinic acid at two distinct dose levels in combination with 5-fluorouracil (5FU) for the treatment of advanced colorectal cancer: experience of the Mayo Clinic and North Central Cancer Treatment Group. in: “International Symposium on the Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy,” Y. Rustum and J. McGuire, eds., Plenum Press, New York, 1988, pp.
N. Petrelli, L. Herrera, Y. Rustum, et al. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol 5: 1559 (1987).
F.H. Valone, P.S. Wittlinger. M.S. Flam, et al. A Northern California Oncology Group randomized trial of single agent 5-FU vs. high-dose folinic acid + 5-FU vs. methotrexate + 5-FU + folinic acid in patients with disseminated measurable large bowel cancer. in: “International Symposium on the Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy.” Y. Rustum and J. McGuire, eds., Plenum Press. New York. 1988. pp.
C. J. Allegra. G.F. Egan, J.C. Drake, et al. The treatment of metastatic breast cancer with 5-fluorouracil and leucovorin. in: “International Symposium on the Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy.” Y. Rustum and J. McGuire, eds., Plenum Press, New York, 1988, pp.
J.H. Doroshow, L. Leong, K. Margolin. et al. Effective salvage therapy for refractory disseminated breast cancr with 5-fluorouracil and high-dose continuous infusion folinic acid. in: “International Symposium on the Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy,” Y. Rustum and J. McGuire, eds., Plenum Press, New York, 1988, pp.
C.L. Loprinzi, J.N. Ingle, D.J. Schaid, et al. Progress report on a phase II trial of 5-fluorouracil plus citrovorum factor in women with metastatic breast cancer. in: “International Symposium on the Expanding Role of Folates and Fluóropyrimidines in Cancer Chemotherapy,” Y. Rustum and J. McGuire, eds., Plenum Press, New York, 1988, pp.
G. Marini, E. Simoncini, A. Zaniboni, et al. Fluorouracil and high-dose folinic acid as salvage treatment of advanced breast cancer: an update. Oncology 44: 336 (1987).
S. Fine, C. Erlichman, L. Kaizer, et al. Phase II trial of 5FU + folinic acid (FA) as first line treatment for metastatic breast cancer. Proc Am Soc Clin Oncol 7: 41 (1988).
A. Zaniboni, E. Simoncini, P. Marpicati, et al. Cyclophosphamide (C), epirubicin (E), high-dose folinic acid (HDFA) and 5-fluorouracil (5-FU) as first line chemotherapy in metastatic breast cancer (MBC). Preliminary results. Proc Am Soc Clin Oncol 7: 18 (1988).
D. Machover, E. Goldschmidt, P. Chollet, et al. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J Clin Oncol 4: 685 (1986).
S.G. Arbuck, H.O. Douglass, Jr., F. Trave, et al. A phase II trial of 5-fluorouracil and high-dose intravenous leucovorin in gastric carcinoma. J Clin Oncol 5: 1150 (1987).
H. W. Bruckner. Mount Sinai clinical experience with leucovorin and fluorouracil. in: “International Symposium on the Expanding Role of Folates and Fluóropyrimidines in Cancer Chemotherapy,” Y. Rustum and J. McGuire, eds., Plenum Press, New York, 1988, pp.
P.J. Creaven, H. Takita, Y. Rustum, et al. Unpublished data.
R.M. Evans, J.D. Laskin, M.T. Hakala. Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil. Cancer Res 41: 3288 (1981).
S. Madajewicz, J.J. Fiore, M.H. Zarrabi. Clinical experience with 5-FU/DDP + OHDW combination chemotherapy in patients with advanced colorectal carcinoma. in: “International Symposium on the Expanding Role of Folates and F1uóropyrimidines in Cancer Chemotherapy,” Y. Rustum and J. McGuire, eds., Plenum Press, New York, 1988, pp.
W. Scheithauer, D. Depisch, R. Schiessel, et al. High dose leucovorin (CF), 5-fluorouracil (5-FU) and cisplatin (DDP) for treatment of metastatic colorectal cancer. Proc Am Soc Clin Oncol 7: 108 (1988).
V. Chiarion Sileni, F. Figoli, M. Gulisano, et al. 120 Hours 5-fluorouracil (5-FU) continuous infusion (c. i.) plus cisplatinum (P) and folinic acid (F) in metastatic colon cancer (M.C.C.). Proc Am Soc Clin Oncol 7: 109 (1988).
T.M. Loeffler, J. Lindemann, H. Luckhaupt, et al. Chemotherapy of advanced and relapsed squamous cell cancer of the head and neck with split-dose cisplatinum (DDP), 5-fluorouracil (Fura) and leucovorin (CF). in: “International Symposium on the Expanding Role of Folates and Fluóropyrimidines in Cancer Chemotherapy,” Y. Rustum and J. McGuire, eds., Plenum Press, New York, 1988, pp.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Plenum Press, New York
About this chapter
Cite this chapter
Creaven, P.J. (1988). 5-Fluorouracil and Folinic Acid: Summary of Clinical Experience. In: Rustum, Y., McGuire, J.J. (eds) The Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy. Advances in Experimental Medicine and Biology, vol 244. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-5607-3_33
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5607-3_33
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4684-5609-7
Online ISBN: 978-1-4684-5607-3
eBook Packages: Springer Book Archive